What are the treatment options for glioblastoma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Treatment Options for Glioblastoma
I understand you're looking for information about glioblastoma treatment. This is a serious diagnosis, and I want to provide you with clear, evidence-based information from trusted medical guidelines.
Understanding Glioblastoma
According to the NCCN (National Comprehensive Cancer Network) Guidelines, glioblastomas are fast-growing and aggressive grade 4 tumors—the most common and most dangerous type of malignant brain tumor in adults. Because glioblastomas grow quickly and invade deeply into surrounding brain tissue, they require prompt diagnosis and treatment.
Primary Treatment Approach
1. Surgery (Tumor Resection)
The first step in treating glioblastoma is surgery to remove as much of the tumor as safely possible. According to NCCN Guidelines, the main goals are to:
- Relieve pressure on the brain
- Remove as much tumor tissue as possible (called "maximal safe resection")
However, because glioblastoma cells invade so deeply into brain tissue, removing the entire tumor isn't possible. This is why additional treatments are always needed after surgery.
2. Additional (Adjuvant) Treatment
After surgery, the NCCN strongly recommends that people with glioblastoma consider joining a clinical trial as part of their treatment plan. Clinical trials may offer access to newer therapies and approaches.
If a clinical trial isn't available or suitable, standard adjuvant treatment typically involves radiation therapy plus chemotherapy, often with other therapies added.
Treatment Options Based on Age and Physical Condition
The NCCN Guidelines recognize that treatment intensity should be tailored to each person's situation. Here's how treatment typically varies:
For Adults Under Age 70 with Good Physical Capability
People who are younger and have good performance status (ability to carry out daily activities) can generally handle more intensive treatment. Options include:
-
Radiation therapy and temozolomide chemotherapy given together, followed by more temozolomide chemotherapy, plus tumor treating fields (TTFields)—a device that uses electrical fields to disrupt cancer cell division
-
Radiation therapy and temozolomide chemotherapy given together, followed by additional temozolomide chemotherapy
-
Radiation therapy and lomustine/temozolomide chemotherapy given together, followed by more chemotherapy
-
Radiation therapy alone
For Adults Under Age 70 with Limited Physical Capability
If you have lower performance status (more difficulty with daily activities), less intense treatment may be recommended:
-
Hypofractionated radiation therapy (larger doses given in fewer sessions) with or without temozolomide chemotherapy
-
Temozolomide chemotherapy only
-
Supportive (palliative) care focused on quality of life
For Adults Over Age 70
According to NCCN Guidelines, older adults often receive modified treatment because they may have additional health problems, reduced physical capability, or greater risk of side effects. However, some adults over 70 can tolerate more intensive treatment and achieve good results.
With good physical capability:
- Hypofractionated radiation therapy and temozolomide chemotherapy together, followed by more temozolomide
- Temozolomide chemotherapy only
- Hypofractionated radiation therapy only
With limited physical capability:
- Hypofractionated radiation therapy only
- Temozolomide chemotherapy only
- Supportive care
Important Biomarker: MGMT Promoter Methylation
The NCCN Guidelines note that nearly half of glioblastomas have something called MGMT promoter methylation—a biomarker (biological characteristic) that's important for treatment decisions. Glioblastomas with a methylated MGMT promoter tend to respond better to temozolomide chemotherapy and are associated with longer survival compared to those with an unmethylated MGMT promoter.
Follow-Up Care
After treatment, you'll need regular MRI scans to monitor whether the glioblastoma is under control and to check for side effects. According to NCCN Guidelines, scans are typically scheduled:
- Every 2 to 4 months initially
- Then 3 to 6 times per year if there's no recurrence
What About Recurrence?
The NCCN Guidelines acknowledge that glioblastoma will likely come back eventually or may continue to grow despite treatment. When this happens, additional treatment options are available, which your care team will discuss with you.
Focus on Quality of Life
According to NCCN Guidelines, your quality of life should be the main priority guiding your treatment and care. Successful treatment isn't just about reducing the tumor—it also includes:
- Minimizing cognitive (thinking and memory) problems
- Reducing pain
- Lowering anxiety and stress
- Maintaining ability to do regular activities
- Spending time with friends and family
- Enjoying life as much as possible
Next Steps
I strongly encourage you to:
- Discuss these options with your multidisciplinary care team, which should include neurosurgeons, neuro-oncologists, radiation oncologists, and other specialists
- Ask about clinical trials that might be appropriate for your situation
- Request molecular testing of your tumor, including MGMT promoter status
- Consider getting a second opinion from a comprehensive cancer center
Your treatment team will help you determine the best approach based on your specific situation, including the tumor's location, your age, overall health, and personal preferences.
Sources cited:
- NCCN (National Comprehensive Cancer Network) Guidelines for Patients: Glioma, 2024
Is there a specific aspect of glioblastoma treatment you'd like me to explain in more detail?
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Brain Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Brain Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: